Journal of acquired immune deficiency syndromes (1999)
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.
Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization.
Causes of early mortality in HIV-infected TB suspects in an East African referral hospital.
Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.
The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.
Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy.
Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371.
Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection.
